+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cell Therapy Market - Global Forecast 2026-2032- Product Image
Stem Cell Therapy Market - Global Forecast 2026-2032- Product Image
New

Stem Cell Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336434
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Amid fast-paced scientific progress and evolving regulations, the stem cell therapy market offers significant potential for organizations positioned to respond strategically. Senior executives must balance innovation, partnership, and operational excellence to capture emerging opportunities across clinical and commercial domains.

Market Snapshot: Stem Cell Therapy Market Growth Outlook

The stem cell therapy market advanced from USD 5.08 billion in 2025 to USD 5.79 billion in 2026, maintaining strong momentum. Projections indicate growth at a CAGR of 14.79%, with expectations of reaching USD 13.35 billion by 2032. This expansion is fueled by breakthroughs in cell engineering, manufacturing platforms, and steady global investment in regenerative medicine. As scientific and industrial capabilities mature, the market is seeing greater adoption across innovative medical applications, solidifying its role within the broader biopharmaceutical landscape.

Scope & Segmentation: Diverse Modalities, Technology Platforms, and Regional Markets

  • Treatment Modalities: Allogeneic therapies leverage donor-derived stem cells for scalability, while autologous solutions use patients’ own cells, offering immune compatibility and customization for individual patient needs.
  • Cell Origin: Adult stem cells—including hematopoietic, mesenchymal, and neural—are prevalent in research and clinical use. Embryonic stem cells, induced pluripotent stem cells, and perinatal sources such as amniotic and umbilical tissue further expand the available therapy pipeline.
  • Technologies: Core technology platforms span biomaterial matrices that support cell growth, gene editing tools for targeted functional modifications, scaffold-based constructs for improved tissue integration, and ex vivo expansion systems promoting scalability and efficiency.
  • Delivery Routes: Approaches include intra-articular, intramuscular, and intravenous administration, focusing on safety and precise targeting. Minimally invasive options are increasingly preferred for patient acceptance and reduced complication risk.
  • Applications: Therapies address conditions ranging from cardiovascular and hematological disorders to musculoskeletal, neurological, and oncology needs. Applications also include platforms for drug discovery and tissue regeneration.
  • End Users: Key adoption centers include academic research institutions, biopharmaceutical firms, clinical providers, and dedicated stem cell banks supporting quality control, storage, and logistics.
  • Geographic Coverage: The market spans the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. Each presents distinct regulatory frameworks and commercial environments, driving region-specific adoption and opportunity.

Key Takeaways: Strategic Advances and Market Considerations

  • Stem cell therapy is being shaped by technological evolution, with gene editing and bioprinting accelerating its shift towards personalized and clinically relevant treatments.
  • Collaboration between industry and academic partners, often through formal consortia, is foundational for standardizing protocols and scaling innovations efficiently.
  • Regulatory agility is increasing in leading markets, easing entry for novel therapy solutions while ensuring improved standards for safety and process traceability.
  • Resilient supply chain strategies, such as deploying localized production hubs and digital traceability, help organizations manage risks related to global disruptions and compliance.
  • Digital health integrations are supporting data-driven patient monitoring and feedback, driving improved therapy outcomes and ongoing care quality.
  • Entering new regional markets requires agile, locally tailored engagement to navigate varying reimbursement structures and evolving ethical guidelines.

Tariff Impact: Navigating Trade Policy Challenges in 2025

Recent tariff proposals in the United States have significantly impacted the global stem cell therapy supply chain. Increased import duties on core inputs and bioprocessing equipment are raising costs and lengthening procurement cycles. Companies are mitigating these effects by diversifying suppliers and establishing manufacturing centers outside the US, driving both cost efficiency and compliance with clinical standards.

Organizations are also investing in real-time digital monitoring and upgrading cold-chain logistics to comply with changing regulations on traceability and cross-border shipments. Such initiatives are critical for continuity in therapy delivery while safeguarding against the risks associated with regulatory changes and supply disruptions.

Methodology & Data Sources

This analysis is informed by a multi-layered research approach. It integrates systematic review of scientific literature, regulatory documents, and leading industry reports. Direct interviews with industry leaders, market experts, and regulators provide primary insights, complemented by rigorous data triangulation to ensure robust, reliable results.

Why This Report Matters

  • Delivers actionable intelligence on disruptive technologies, shifting regional regulations, and collaborative innovation models shaping the stem cell therapy market’s future.
  • Enables proactive strategic planning, equipping leaders with practical guidance for managing supply chain risk, tariff exposure, and operational scaling.
  • Supports commercial planning and stakeholder alignment through detailed, validated segmentation and mapping essential for resource allocation.

Conclusion

Executives who leverage these insights will be ready to steer their organizations through an evolving terrain, unlocking therapeutic innovation, market opportunities, and sustained growth in the dynamic stem cell therapy sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Stem Cell Therapy Market, by Therapy Type
8.1. Allogeneic Therapy
8.2. Autologous Therapy
9. Stem Cell Therapy Market, by Cell Source
9.1. Adult Stem Cells
9.1.1. Hematopoietic Stem Cells
9.1.2. Mesenchymal Stem Cells
9.1.3. Neural Stem Cells
9.2. Embryonic Stem Cells
9.3. Induced Pluripotent Stem Cells
9.4. Perinatal Stem Cells
9.4.1. Amniotic Fluid Stem Cells
9.4.2. Umbilical Cord Stem Cells
10. Stem Cell Therapy Market, by Technology
10.1. Biomaterial Based Therapy
10.2. Ex Vivo Expansion
10.3. Gene Edited Technologies
10.4. Scaffold Based Therapy
11. Stem Cell Therapy Market, by Mode of Administration
11.1. Intra-articular
11.2. Intramuscular
11.3. Intravenous
12. Stem Cell Therapy Market, by Application
12.1. Drug Discovery & Development
12.2. Regenerative Medicine
12.3. Tissue Engineering
13. Stem Cell Therapy Market, by Therapeutic Areas
13.1. Cardiovascular Diseases
13.2. Hematology
13.3. Musculoskeletal Disorders
13.4. Neurological Disorders
13.5. Oncology
14. Stem Cell Therapy Market, by End User
14.1. Academic & Research Institutes
14.2. Biopharmaceutical Companies
14.3. Hospitals & Clinics
14.4. Stem Cell Banks
15. Stem Cell Therapy Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Stem Cell Therapy Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Stem Cell Therapy Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Stem Cell Therapy Market
19. China Stem Cell Therapy Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Anterogen Co., Ltd.
20.6. Astellas Pharma Inc.
20.7. Beike Biotechnology Co., Ltd.
20.8. BrainStorm Cell Therapeutics Inc.
20.9. Bristol-Myers Squibb Company
20.10. CellProthera SAS
20.11. Fate Therapeutics, Inc.
20.12. Gamida Cell Ltd.
20.13. Garuda Therapeutics
20.14. Holostem Terapie Avanzate S.r.l.
20.15. Jasper Therapeutics, Inc.
20.16. JCR Pharmaceuticals Co., Ltd.
20.17. Juvena Therapeutics Inc.
20.18. Kangstem Biotech Co., Ltd.
20.19. Kite Pharma, Inc. by Gilead Sciences, Inc.
20.20. Lonza Group AG
20.21. Medeze Group
20.22. Merck KGaA
20.23. Mesoblast Ltd.
20.24. Novo Nordisk A/S
20.25. Plasticell
20.26. ReNeuron Group PLC
20.27. SQZ Biotechnologies Company by Stemcell Technologies
20.28. Takara Bio Inc.
20.29. Thermo Fisher Scientific Inc.
20.30. U.S. Stem Cell Inc
20.31. Umoja Biopharma
20.32. Vericel Corporation
List of Figures
FIGURE 1. GLOBAL STEM CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL STEM CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL STEM CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES STEM CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA STEM CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL STEM CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEURAL STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEURAL STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEURAL STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMNIOTIC FLUID STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMNIOTIC FLUID STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMNIOTIC FLUID STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL STEM CELL THERAPY MARKET SIZE, BY UMBILICAL CORD STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL STEM CELL THERAPY MARKET SIZE, BY UMBILICAL CORD STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL STEM CELL THERAPY MARKET SIZE, BY UMBILICAL CORD STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOMATERIAL BASED THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOMATERIAL BASED THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOMATERIAL BASED THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EX VIVO EXPANSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EX VIVO EXPANSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EX VIVO EXPANSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GENE EDITED TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GENE EDITED TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GENE EDITED TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL STEM CELL THERAPY MARKET SIZE, BY SCAFFOLD BASED THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL STEM CELL THERAPY MARKET SIZE, BY SCAFFOLD BASED THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL STEM CELL THERAPY MARKET SIZE, BY SCAFFOLD BASED THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRA-ARTICULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRA-ARTICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL STEM CELL THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL STEM CELL THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL STEM CELL THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL STEM CELL THERAPY MARKET SIZE, BY STEM CELL BANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL STEM CELL THERAPY MARKET SIZE, BY STEM CELL BANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL STEM CELL THERAPY MARKET SIZE, BY STEM CELL BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS STEM CELL THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. EUROPE STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 146. EUROPE STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 147. EUROPE STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 148. EUROPE STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. EUROPE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 164. AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 166. AFRICA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 167. AFRICA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. AFRICA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 169. AFRICA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 171. AFRICA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. ASEAN STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASEAN STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 185. ASEAN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 186. ASEAN STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 187. ASEAN STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 188. ASEAN STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 189. ASEAN STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 190. ASEAN STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. ASEAN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 192. ASEAN STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. GCC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GCC STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 195. GCC STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 196. GCC STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 197. GCC STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 198. GCC STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 199. GCC STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. GCC STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. GCC STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 202. GCC STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. BRICS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. BRICS STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 215. BRICS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 216. BRICS STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 217. BRICS STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 218. BRICS STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 219. BRICS STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 220. BRICS STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. BRICS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 222. BRICS STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. G7 STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. G7 STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 225. G7 STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 226. G7 STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 227. G7 STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 228. G7 STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 229. G7 STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 230. G7 STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. G7 STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 232. G7 STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. NATO STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. NATO STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 235. NATO STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 236. NATO STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 237. NATO STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 238. NATO STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. NATO STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 240. NATO STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. NATO STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 242. NATO STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES STEM CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. CHINA STEM CELL THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 255. CHINA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 256. CHINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2032 (USD MILLION)
TABLE 257. CHINA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2032 (USD MILLION)
TABLE 258. CHINA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 259. CHINA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 260. CHINA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 261. CHINA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. CHINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2032 (USD MILLION)
TABLE 263. CHINA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Stem Cell Therapy market report include:
  • Animal Cell Therapies, Inc.
  • Anterogen Co., Ltd.
  • Arthrex Vet Systems by Arthrex Inc.
  • Astellas Pharma Inc.
  • Beike Biotechnology Co., Ltd.
  • BrainStorm Cell Therapeutics Inc.
  • Bristol-Myers Squibb Company
  • Celavet Inc.
  • Cell Therapy Sciences
  • CellProthera SAS
  • Elanco Animal Health
  • Fate Therapeutics, Inc.
  • Gamida Cell Ltd.
  • Garuda Therapeutics
  • Holostem Terapie Avanzate S.r.l.
  • Jasper Therapeutics, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Juvena Therapeutics Inc.
  • Kangstem Biotech Co., Ltd.
  • Kintaro Cells Power
  • Kite Pharma, Inc. by Gilead Sciences, Inc.
  • Lonza Group AG
  • Magellan Stem Cells
  • Medeze Group
  • Medivet Biologics LLC
  • Merck KGaA
  • Mesoblast Ltd.
  • Molecare Pet Vets
  • Novo Nordisk A/S
  • Okyanos Global Health
  • PetVet Care Centers
  • Plasticell
  • Redstone Veterinary Hospital.
  • Regeneus Ltd.
  • ReNeuron Group PLC
  • SQZ Biotechnologies Company by Stemcell Technologies
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • U.S. Stem Cell Inc
  • Umoja Biopharma
  • Vericel Corporation
  • Vetbiologics
  • VetCell Therapeutics
  • VetStem Biopharma
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.79 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.35 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned46

Related Topics

Related Reports

Stem Cell Therapy for Premature Ovarian Failure Market - Global Forecast 2025-2030 - Product Image

Stem Cell Therapy for Premature Ovarian Failure Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Diabetes Stem Cell Therapy Global Market Report 2025 - Product Image

Diabetes Stem Cell Therapy Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Stem Cell Therapy Market Report 2025 - Product Image

Stem Cell Therapy Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Stem Cell Therapy Market Report and Forecast 2025-2034 - Product Image

Stem Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Stem Cell Therapy Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Stem Cell Therapy Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 85 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.